Cargando…
Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
The anti-CD20 antibody ocrelizumab, approved for treatment of multiple sclerosis, leads to rapid elimination of B cells from the blood. The extent of B cell depletion and kinetics of their recovery in different immune compartments is largely unknown. Here, we studied how anti-CD20 treatment influenc...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
National Academy of Sciences
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166805/ https://www.ncbi.nlm.nih.gov/pubmed/30194232 http://dx.doi.org/10.1073/pnas.1810470115 |